Clinical Trials for To Evaluate the Rate of Digestive and Urinary Toxicity

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk

NCT ID: NCT03417336

This clinical trial is studying a new way to treat patients with high-risk prostate cancer, specifically looking at how well a special type of radiation therapy works and how it affects patients’ d...